Occupational Asthma Management Beyond the Textbooks Paul Cullinan MD, FRCP

Similar documents
Diagnosis, management and prevention of occupational asthma

BOHRF BOHRF. Occupational Asthma. A Guide for Occupational Health Professionals, Safety Professionals and Safety Representatives BOHRF

Occupational asthma. Dr Gordon Parker NHS. Consultant / Honorary Lecturer in Occupational Medicine. Lancashire Teaching Hospitals NHS Foundation Trust

OCCUPATIONAL ASTHMA A GUIDE FOR GENERAL PRACTITIONERS AND PRACTICE NURSES

OCCUPATIONAL ASTHMA A GUIDE FOR OCCUPATIONAL PHYSICIANS AND OCCUPATIONAL HEALTH PRACTITIONERS

2/28/2018. Occupation and Allergy The Basics and Not So Basics. Occupation and Allergy The Basics and Not So Basics. Outline

Evaluations. Featured Speakers. Work Related Asthma: Recognition and Diagnosis. Disclosure Statements. Thank You to Our Sponsors: June 19, 2014

Work related asthma: a brief review. October 12, 2015 Mike Pysklywec MD MSc CCFP(EM) DOHS FCBOM

THE UNIVERSITY OF WESTERN ONTARIO Department of Epidemiology & Biostatistics. F. Lortie-Monette, MD, MSc, CSPQ, MBA OCCUPATIONAL ASTHMA

Health Surveillance. Reference Documents

Asthma is a common condition, often starting or recurring

STHMA IN THE WORKPLACE INFORMATION AND PREVENTION RF-531

Work-related Asthma. Discussion paper prepared for. The Workplace Safety and Insurance Appeals Tribunal

New Hazards and Trends in Occupational Asthma

Occupational asthma PAUL CULLINAN AND ANTHONY NEWMAN TAYLOR INTRODUCTION

Clinical Diagnosis of Occupational Asthma practice and challenges/opportunities ECETOC 2016

Asthma in the workplace

Novel biomarkers of chemical-induced asthma: a murine model. Jeroen Vanoirbeek

ISOPA PRODUCT STEWARDSHIP PROGRAMMES. Walk the Talk MDI USERS

American Osteopathic College of Occupational and Preventive Medicine 2011 Annual Meeting, Orlando, Florida, November 1, 2011

Occupational Asthma in New Zealand Jeroen Douwes

O ccupational asthma (OA) is the most commonly

Isocyanate asthma: respiratory symptoms due to 1,5-naphthylene di-isocyanate

SOLDER FUME and you 1

ISOPA PRODUCT STEWARDSHIP PROGRAMMES. Walk the Talk MDI USERS

ISOPA PRODUCT STEWARDSHIP PROGRAMMES. Walk the Talk MDI USERS. 1 Version09/06

The Compensation of Allergic Disease ALLSA Conference, September 2017

BOHRF BOHRF BOHRF BOHRF

Revised Protocol: Criteria for Designating Substances as. Occupational Asthmagens on the AOEC List of. Exposure Codes

Safety First Plus. Safety, Health and Environment (SHE) Prevention of Work Related Skin Disease. Maritime Submarines SAFETY FIRST PLUS

Enzyme Safety Management: Thanks for joining us today!

Health and Safety in Nail Salons

The Health and Occupation Research Network THOR ( UK & Republic of Ireland )

Name Of Substance & [EINECS No] Concentration Symbol R Phrases n-butyl acetate[ ] 1-10 % R Hexamethylene diisocyanate[ ]

Changing Patterns of Occupational Respiratory Disease. Malcolm Sim

SOLDER Revision Date: 30/05/2003

Prepared by Sarah Bozeman, MD, University of Mississippi Healthcare, and John Seyerle, Ohio State University

Health Consequences of Exposure to Green Polyurethane Spray Foam

Your health and safety guide to Hazardous substances

Occupational asthma in a steel coating plant

Allwin Mercer Dr Andrew Zurek

Effect of peak expiratory flow data quantity on diagnostic sensitivity and specificity in occupational asthma

Practical Issues in Asthma Management OCCUPATIONAL ASTHMA. Dr. P. Sherwood Burge, Consultant Physician, Birmingham Heartlands Hospital, Birmingham, UK

HEALTH AND SAFETY DATA SHEET

Occupational Asthma and Work- Exacerbated Asthma* Factors Associated With Time to Diagnostic Steps

B R E ATHE FR EELY. Do you breathe freely? Controlling exposures to prevent occupational lung disease in the construction industry

SAFETY DATA SHEET. Use of substance / mixture: FOR PROFESSIONAL USE ONLY 2 Parts of G-Fix Gold Resin to be used with 1 Part G-Fix Gold Hardener.

Latex allergy. Occupational aspects of management

Bronchial provocation testing. ICOH Mexico David Lee Sherson, Odense. (Paul Cullinan, London)

PRODUCT SAFETY DATA SHEET

Exposure to Mineral and Chemical Hazards

and Air Sampling - Construction Industry

Work-related asthma, Dr Ryan Hoy Alfred Hospital, Melbourne Monash Centre for Occupational and Environmental Health

Safety Data Sheet PT25R

Version 1.1 SDB_GB Revision Date Print Date Identification of the substance/mixture and of the company/undertaking

Control of Substances Hazardous to Health (COSHH) Regulations 2002

: Corian Joint Adhesive Kit - Component A

Guidelines for Addressing Allergies and Sensitivities in the Workplace Next review: April 2019 I. PURPOSE II. INTRODUCTION III.

ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss?

ASTHMA PROTOCOL CELLO

Diagnosis, Treatment and Management of Asthma

information Chronic Obstructive Pulmonary Disease - COPD (1 of 5) What is COPD? What is going on in my lungs? What are the symptoms of COPD?

Guidelines for the management of work-related asthma

Chronic Cough. Dr Peter George Consultant Respiratory Physician Royal Brompton and Harefield Hospitals

Safety Data Sheet EPOJET LV parte A

Get Healthy Stay Healthy

Dermatitis. Occupational aspects of management

Marks & Spencer Homecare Products Ingredients and Safety Data Sheet

Pathology of Asthma Epidemiology

SAFETY DATA SHEET SAWCUT 1000 Page: 1 Compilation date: 12/04/2016 Revision No: 1

SAFETY DATA SHEET according to Regulation (EU) 2015/830

Asthma: diagnosis and monitoring

This SDS adheres to the standards and regulatory requirements of Great Britain and may not meet the regulatory requirements in other countries.

Coating powders are mixtures of pigments, resins, curing. As the coating powder is sprayed through the nozzle of the

Before you start go to page 2. Leeds West Clinical Commissioning Group

1. Identification of the substance/mixture and of the company/undertaking

material safety data sheet

MATERIAL SAFETY DATA SHEET. Product Pirtek Hydraulic HVI Range Page 1 of 5 Date Oct Revision 02

HEALTH & SAFETY DATA SHEET

WORK-RELATED ASTHMA: Michael Pysklywec Sonia Lal

SAFETY DATA SHEET. Section 1: Identification of the substance/mixture and of the company/undertaking. Section 2: Hazards identification

Asthma-like syndrome in school children after accidental exposure to xylene and methylene diphenyl diisocyanate

SAFETY DATA SHEET. Section 1: Identification of the substance/mixture and of the company/undertaking. Section 2: Hazards identification

Material Safety Data Sheet acc. to ISO/DIS 11014

Material Safety Data Sheet

Safety Data Sheet MAPEPROOF ESM parte A

OCCUPATIONAL DERMATITIS

SUMMARY DECISION NO. 718/98. Asthma.

Diagnosis and Management of Asthma in Children based on the British Thoracic Society and Scottish Intercollegiate Guidelines Network September 2016

Inhalation challenges with agents causing occupational asthma

1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING RIO BUCATO BIMBO. Liquid laundry detergent for machine and hand usage

Asthma Description. Asthma is a disease that affects the lungs defined as a chronic inflammatory disorder of the airways.

Safety Data Sheet ULTRAPLAN RENOVATION

Occupational asthma in an electronics factory

Stowe School Asthma Policy

Material Safety Data Sheet acc. to ISO/DIS 11014

Who Is at Risk for Asthma? Who develope asthma?

Outpatient Guideline for the Diagnosis and Management of Asthma

MATERIAL SAFETY DATA SHEET

Transcription:

Occupational Asthma 1 Professor of Occupational and Environmental Medicine Royal Brompton Hospital and Imperial College London LUNGS AT WORK www.lungsatwork.org.uk Premise and plan Good respiratory physicians know a lot about occupational asthma But don t often see it And may not be sure about some of the intricacies Occupational asthma is rarely severe asthma but its consequences often are Intricacies by a single case report 2 Consider 3 47 year old No relevant past medical history Non-smoker September 2008: short of breath Dx chest infection by GP Christmas 2008: short of breath + wheeze 1/52 hospital Dx asthma Rx asthma since February 2009: returned to work Symptoms persist but better 2 week holiday in Crete: symptoms resolved Q1: what other information do you need? 1

Consider an occupational aetiology In every working adult with asthma that is: New Recurrent, or Deteriorating/Proving difficult to manage Especially if they are working with a recognised respiratory sensitising agent 4 Consider 22 years work in a factory making foam insulating board New process January 2008 5 6 2

7 Consider 22 years work in a factory making foam insulating board New process January 2008 8 Q2: is it possible that his work is causally related to his diagnosis of asthma? or Is he working with a recognised respiratory sensitising agent? Most occupational asthma arises from specific sensitisation An agent at work is: Known to be a respiratory sensitiser (n 400) Known not to be a respiratory sensitiser Not known not to be respiratory sensitiser The last is tricky 9 3

Is your patient working with a respiratory sensitising agent? Agent on my familiar list? Consider OA 10 Respiratory sensitising agents: high molecular mass - Whole allergens 11 Occupation Baking Animal work Food processing Detergent manufacture Health care Exposure(s) Flour(s) Alpha amylase ( improver ) Egg Small mammals Large mammals Insects Latex Seafood Tea/coffee Eggs Flour Latex Etc. Enzymes Latex All induce specific IgE response Respiratory sensitising agents: low molecular mass + - Hapten-protein conjugates Occupation Spray painting Foam manufacture Electronic engineering Woodwork Hairdressing Dentistry Orthopaedics Textile printing Precious metal refining Exposure(s) Hexamethylene diisocyanate Toluene diisocyanate Methylene diphenyldiisocyanate Colophony fume Cyanoacrylate Persulphate salts Tropical wood dusts Persulphate salts Methacrylates Latex Reactive dyes Platinum salts 12 Some induce specific IgE response 4

Is your patient working with a respiratory sensitising agent? Agent on my familiar list? No/Not sure Seek advice obtain MSDS Consider OA R42? 13 No Take care Safety Data Sheet TECHNI GOLD 25 ES RTU TGOLD25ES/0 Page n. 1 of 4 Safety Data Sheet dated 23/7/2004, version 0 1. IDENTIFICATION OF THE PRODUCT AND THE COMPANY Trade name: TECHNI GOLD 25 ES RTU Trade code: TGOLD25ES Supplier: TECHNIC FRANCE 15rue de la Montjoie 93212 St Denis La Plaine 2. COMPOSITION/INFORMATION ON INGREDIENTS Hazardous components within the meaning of EEC directive 67/548 and corresponding classification: 1% - 5% sodium sulfite R20/22 1% - 5% ethylenediamine R10 R21/22 R34 R42/43 1% - 3% sulphuric acid R35 3. HAZARDS IDENTIFICATION If brought into contact with the eyes, the product causes irritation that may last for over 24 hours, and if brought into contact with the skin it causes significant inflammation with erythema, scabs, and oedema. If inhaled, the product may cause sensitisation of the airways, and if brought into contact with the skin it may cause sensitisation of the skin 14 All airborne proteins are (potentially) sensitising agents Many chemicals with powerful odours are not... 15 Solvents Thinners Perfumes Many (but not all) glues Some tips......and are thus improbable causes of sensitisation Be wary of diagnosing occupational asthma in anyone who is not working with a recognised respiratory sensitising agent 5

Recall 22 years work in a factory making foam insulating board New process January 2008 Q2: is he working with a recognised respiratory sensitising agent?... foam is a polymer made using polyol and MDI MDI = methylene phenyldiisocyanate 16 Hence Adult onset asthma Shortly after introduction of new process Works with known respiratory sensitising agent Symptoms improve on holiday Q3: what is the (prior) probability that this man has occupational asthma? Q4: how important is it to know (and how certain do you want to be)? 17 Occupational asthma or work-exacerbated asthma Occupational asthma (OA): That which has arisen de novo from an exposure encountered at work Work-exacerbated asthma (WEA): Pre-existing, recurrent or coincidental asthma that is exacerbated by exposure(s) in the workplace 18 6

Occupational asthma or work-exacerbated asthma: why does it matter? Continued exposure: Treatment: RPE: Cure? Legal? Relocation: Compensation: OA Worsens prognosis Useless Often useless (but ) 19 Occupational asthma or work-exacerbated asthma: why does it matter? OA WEA Continued exposure: Worsens prognosis Doesn t affect prognosis Treatment: Useless Effective RPE: Often useless Effective Cure? (but ) No Legal? No Relocation: Generally no Compensation: yes No 20 Getting it right matters Locating your patient: understanding the context (UK) In-house External provider Family doctor Occupational health (Surveillance) HSE Referral for opinion R I D D O R Case of OA Employer 21 Avoidance of further exposure relocation 7

Relocation of an employee with occupational asthma Avoidance of further exposure Retention in job, adjustment to tasks Re-training, protected position Re-location within firm Redundancy Size of workforce Attitude of employer/oh Experience of OA Self-employed 22 23 So... Are you sure that you (both) want to go the whole way? On the one hand: You have a good chance of curing their asthma You will certainly stop it getting worse If you miss an occupational cause then treatment is useless On the other: They are likely to suffer major disruption at work and may become fairly unpopular there They may very well need to change (lose) their job and find it difficult to get another Hence: Getting it wrong can be disastrous Beware being on the safe side 24 Back to the case 1 Adult onset asthma Shortly after introduction of new process Works with known respiratory sensitising agent Symptoms improve on holiday Q5: is immunology going to be helpful? Negative specific IgE test for MDI Specific IgE in diisocyanate asthma is of: Low sensitivity (lots of false negatives) High specificity (few false positives) Hence helpful if positive 8

Using immunology intelligently in occupational asthma No, or not sure Is it a protein? IgE tests are: Highly sensitive Widely available Hence helpful when negative Ask for the right one(s) 25 Ask for expert help Back to the case 2 Adult onset asthma Shortly after introduction of new process Works with known respiratory sensitising agent Symptoms improve on holiday Specific immunology negative Q6: what might you do next? Comparison of function at and away from work Serial measurement of PEF: 26 Every two hours (six times daily) Four weeks At and away from work Plot of daily measurements: Mean Maximum Minimum Peak flow (max, mean, min) L/minute 27 9

28 Now where are you? Adult onset asthma Shortly after introduction of new process Works with known respiratory sensitising agent Symptoms improve on holiday Immunology unhelpful Serial PEFs look negative Q7: is this enough? How sure do you (both) need to be? Is there anything else on offer? Specific inhalation challenge Specific inhalation challenge 29 Controlled exposure to workplace agent Inpatient procedure Requires experience and expertise Available in few centres Used when: Other diagnostic approaches have not proved definitive A previously unrecognised agent is under consideration It s important to distinguish two or more agents Not for legal purposes Results of specific inhalation challenge 30 2 mins polyol 2.5 mins MDI 20 mins MDI 25 mins MDI 15 % change in baseline FEV1 0-15 30-30 0 5 10 15 30 60 2 3 4 5 6 7 8 9 10 Minutes Hours 10

Outcome Back at work Asymptomatic Off treatment Not everything is asthma Probably all infective Note that working with exposed to 31 32 A brief summary Suspect an occupational cause in all cases of new, recurrent or deteriorating asthma in working adults Understand respiratory sensitising agent Have a feeling for your patient s location within the workplace Go in with all (4) eyes open Get it right: A positive diagnosis can be curative A false positive diagnosis can be disastrous Be specific about the agent(s) Act fast Caution is not always the better part of anything 33 11